158 related articles for article (PubMed ID: 37959973)
1. Utilizing Drug Amorphous Solid Dispersions for the Preparation of Dronedarone per os Formulations.
Kapourani A; Manioudaki AE; Kontogiannopoulos KN; Barmpalexis P
Polymers (Basel); 2023 Nov; 15(21):. PubMed ID: 37959973
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of Amorphous Solid Dispersions for Enhancing Luteolin's Solubility in Simulated Saliva.
Koromili M; Kapourani A; Barmpalexis P
Polymers (Basel); 2022 Dec; 15(1):. PubMed ID: 36616519
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Evaluation of Siderol Amorphous Solid Dispersions: Selection of Suitable Matrix/Carrier.
Koromili M; Kapourani A; Koletti A; Papandreou G; Assimopoulou AN; Lazari D; Barmpalexis P
AAPS PharmSciTech; 2022 Aug; 23(6):214. PubMed ID: 35918468
[TBL] [Abstract][Full Text] [Related]
4. Crystallization tendency of APIs possessing different thermal and glass related properties in amorphous solid dispersions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Int J Pharm; 2020 Apr; 579():119149. PubMed ID: 32070762
[TBL] [Abstract][Full Text] [Related]
5. Drug Amorphous Solid Dispersions Based on Poly(vinyl Alcohol): Evaluating the Effect of Poly(propylene Succinate) as Plasticizer.
Kapourani A; Palamidi A; Kontogiannopoulos KN; Bikiaris ND; Barmpalexis P
Polymers (Basel); 2021 Aug; 13(17):. PubMed ID: 34502962
[TBL] [Abstract][Full Text] [Related]
6. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
7. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.
Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E
Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151
[TBL] [Abstract][Full Text] [Related]
8. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
9. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
10. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin.
Myślińska M; Stocker MW; Ferguson S; Healy AM
J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392
[TBL] [Abstract][Full Text] [Related]
12. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
13. Evolution of supersaturation from amorphous solid dispersions in water-insoluble polymer carriers: Effects of swelling capacity and interplay between partition and diffusion.
Schver GCRM; Nadvorny D; Lee PI
Int J Pharm; 2020 May; 581():119292. PubMed ID: 32243967
[TBL] [Abstract][Full Text] [Related]
14. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
15. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Eur J Pharm Biopharm; 2019 Dec; 145():98-112. PubMed ID: 31698042
[TBL] [Abstract][Full Text] [Related]
17. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
20. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
Fan N; Lu T; Li J
J Pharm Sci; 2020 Feb; 109(2):1068-1078. PubMed ID: 31639390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]